Biolargo, Inc. (OTC:BLGO)
| Market Cap | 26.15M-51.0% |
| Revenue (ttm) | 4.08M-71.0% |
| Net Income | -14.48M-271.6% |
| EPS | -0.05-250.4% |
| Shares Out | 320.88M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 271,082 |
| Open | 0.07 |
| Previous Close | 0.08 |
| Day's Range | 0.07 - 0.08 |
| 52-Week Range | 0.07 - 0.20 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 18, 2026 |
Insiders here have filed 4 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About BLGO
BioLargo, Inc. pioneers the invention, development, and commercialization of sophisticated platform technologies. The company is dedicated to tackling critical environmental challenges, such as per- and polyfluoroalkyl substances (PFAS) contamination, advanced water and wastewater purification, managing industrial odors and volatile organic compounds (VOCs), enhancing air quality, and controlling infections. Backed by numerous issued patents, BioLargo maintains a robust product pipeline and extends its expertise through comprehensive environmental engineering services. Among its notable innovations are the Advanced Oxidation system, a water treatment solution generating potent oxidative and energetic iodine species; the Aqueous Electrostatic Concentrator, specifically designed for eliminating PFAS from water; CupriDyne Clean industrial products, which effectively neutralize stubborn odors and VOCs across various industrial settings; and specialized advanced wound care products. Established in 1991, BioLargo, Inc. is headquartered in Westminster, California.
$BLGO stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in BLGO holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by BLGO's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
BLGO Estimated quarterly lobbying spending
Source: U.S. Senate LDA
BLGO Revenue by Segment
| Segment | Revenue | % of All |
|---|---|---|
| Revenue from Contract with Customer, Including Assessed Tax | $1.25M | 50.79% |
| Operating lease right-of use | $927.00K | 37.73% |
| Finance lease right-of-use | $282.00K | 11.48% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New BLGO patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to BLGO from public contracts
Source: USAspending.gov
BLGO Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from BLGO’s recent data — informational, not investment advice